A serine protease is involved in the initiation of DNA damage-induced apoptosis

被引:54
作者
de Bruin, EC [1 ]
Meersma, D [1 ]
de Wilde, J [1 ]
den Otter, I [1 ]
Schipper, EM [1 ]
Medema, JP [1 ]
Peltenburg, LTC [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 RC Leiden, Netherlands
关键词
apoptosis; serine protease; melanoma; PARP;
D O I
10.1038/sj.cdd.4401296
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Caspases are considered to be the key effector proteases of apoptosis. Initiator caspases cleave and activate downstream executioner caspases, which are responsible for the degradation of numerous cellular substrates. We studied the role of caspases in apoptotic cell death of a human melanoma cell line. Surprisingly, the pancaspase inhibitor zVAD-fmk was unable to block cleavage of poly(ADP-ribose) polymerase (PARP) after treatment with etoposide, while it did prevent DEVDase activity. It is highly unlikely that caspase-2, which is a relatively zVAD-fmk-resistant caspase, is mediating etoposide-induced PARP cleavage, as a preferred inhibitor of this caspase could not prevent cleavage. In contrast, caspase activation and PARP degradation were blocked by pretreatment of the cells with the serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF). We therefore conclude that a serine protease regulates an alternative initiation mechanism that leads to caspase activation and PARP cleavage. More importantly, while zVAD-fmk could not rescue melanoma cells from etoposide-induced death, the combination with AEBSF resulted in substantial protection. This indicates that this novel pathway fulfills a critical role in the execution of etoposide-induced programmed cell death.
引用
收藏
页码:1204 / 1212
页数:9
相关论文
共 57 条
  • [1] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [2] Survivin does not inhibit caspase-3 activity
    Banks, DP
    Plescia, J
    Altieri, DC
    Chen, J
    Rosenberg, SH
    Zhang, HC
    Ng, SC
    [J]. BLOOD, 2000, 96 (12) : 4002 - 4002
  • [3] Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers
    Brunet, CL
    Gunby, RH
    Benson, RSP
    Hickman, JA
    Watson, AJM
    Brady, G
    [J]. CELL DEATH AND DIFFERENTIATION, 1998, 5 (01) : 107 - 115
  • [4] Apaf-1 oligomerizes into biologically active ∼700-kDa and inactive ∼1.4-MDa apoptosome complexes
    Cain, K
    Bratton, SB
    Langlais, C
    Walker, G
    Brown, DG
    Sun, XM
    Cohen, GM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) : 6067 - 6070
  • [5] ACTIVATION OF THE APOPTOTIC PROTEASE CPP32 BY CYTOTOXIC T-CELL-DERIVED GRANZYME-B
    DARMON, AJ
    NICHOLSON, DW
    BLEACKLEY, RC
    [J]. NATURE, 1995, 377 (6548) : 446 - 448
  • [6] Blocking apoptosis prevents blindness Drosophila retinal degeneration mutants
    Davidson, FF
    Steller, H
    [J]. NATURE, 1998, 391 (6667) : 587 - 591
  • [7] Serine protease inhibitors suppress cytochrome c-mediated caspase-9 activation and apoptosis during hypoxia-reoxygenation
    Dong, Z
    Saikumar, P
    Patel, Y
    Weinberg, JM
    Venkatachalam, MA
    [J]. BIOCHEMICAL JOURNAL, 2000, 347 (pt 3) : 669 - 677
  • [8] The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program
    Elliott, K
    Ge, K
    Du, W
    Prendergast, GC
    [J]. ONCOGENE, 2000, 19 (41) : 4669 - 4684
  • [9] Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor
    Foghsgaard, L
    Wissing, D
    Mauch, D
    Lademann, U
    Bastholm, L
    Boes, M
    Elling, F
    Leist, M
    Jäättelä, M
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 153 (05) : 999 - 1009
  • [10] Inhibition of human caspases by peptide-based and macromolecular inhibitors
    Garcia-Calvo, M
    Peterson, EP
    Leiting, B
    Ruel, R
    Nicholson, DW
    Thornberry, NA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) : 32608 - 32613